P2Y12 inhibitors: all 610 studies that test it
Page 5 of 7. Open to participants first (61), then studies with results posted, then the rest; newest registration first within each.
- Adenosine-induced Myocardial Blood Flow in Peripheral Artery Disease PatientsWithdrawnNCT02121288Phase 4
- DIAMOND - Dual Antiplatelet Therapy to Reduce Myocardial InjuryCompletedNCT02110303Phase 2/3
- Effect of Ticagrelor on Fractional Flow ReserveCompletedNCT02108808Phase 4
- Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive ManagementCompletedNCT02094963Phase 4
- Clopidogrel And Ticagrelor in Healthy SubjectsCompletedNCT02086903Phase 3
- Triple vs. Dual TherapyCompletedNCT02080858Phase 1
- Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACSTerminatedNCT02071966Phase 4
- Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With CAD.CompletedNCT02071212Phase 2
- The Efficacy of Ticagrelor on Abdominal Aortic Aneurysm (AAA) ExpansionCompletedNCT02070653Phase 2
- Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)CompletedNCT02060786Phase 4
- Transition From Ticagrelor to Clopidogrel Following Acute Coronary Syndrome: To Bolus or Not?CompletedNCT02054663Phase 4
- Genotyping Guided Individualized Treatment of Clopidogrel and Ticagrelor in ACSStatus unknownNCT02048228Phase 2/3
- Comparing Ticagrelor and Clopidogrel Pharmacodynamics After ThrombolysisWithdrawnNCT02048085Phase 4
- OraL Crushed and dIspersed Ticagrelor 180mg Compared to Whole Tablets of eQUal Dose in STEMI Patients unDergoing Primary PCI: a Pharmacokinetic/Pharmacodynamic Study (the LIQUID Study)CompletedNCT02046486Phase 4
- Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)CompletedNCT02044250Phase 4
- A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding RiskCompletedNCT02044146Phase 2/3
- Paradigm Shift in the Treatment of Patients With ACSCompletedNCT02041650Phase 4
- Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary SyndromeTerminatedNCT02037412Phase 4
- Comparison of Clopidogrel and Ticagrelor on Microvascular Dysfunction in ST-Segment Elevation Myocardial InfarctionCompletedNCT02026219Phase 4
- TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMICompletedNCT02018055Phase 4
- Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCIStatus unknownNCT02012140Phase 4
- Ticagrelor and AdenosineCompletedNCT01996735Phase 4
- Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary SyndromeCompletedNCT01994941Phase 4
- Ticagrelor Loading Dose Versus Clopidogrel Loading and Reloading With Ticagrelor.CompletedNCT01961856Phase 3
- Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment For Acute Coronary Syndromes TrialCompletedNCT01959451Phase 4
- Differential Effect of Ticagrelor Versus Prasugrel Maintenance Dose on Endothelial Function of Peripheral Vessels in Patients With Coronary Artery DiseaseCompletedNCT01957540Phase 4
- Effect of Clopidogrel on Allergen Challenge in AsthmaCompletedNCT01955512Phase 2
- OPTImal Management of Antithrombotic Agents: OPTIMA-2 TrialCompletedNCT01955200Phase 4
- Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Post FibrinolysisCompletedNCT01950416Phase 4
- Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary SyndromeCompletedNCT01944800Phase 4
- Ticagrelor for PCI Post ThrombolysisCompletedNCT01930591Phase 3
- Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque InflammationCompletedNCT01905566Phase 4
- Ticagrelor vs Clopidogrel Effect on MFR in CAD PopulationCompletedNCT01894789Phase 2/3
- Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.CompletedNCT01887626Phase 1
- Targeting Platelet-Leukocyte Aggregates in Pneumonia With TicagrelorCompletedNCT01883869Phase 1
- PKPD Study of Ticagrelor and Prasugrel in Healthy Korean MalesCompletedNCT01876797Phase 1
- Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With TicagrelorStatus unknownNCT01869309Phase 4
- Appraisal of MDCO-157 and Plavix® Pharmacokinetics and Pharmacodynamics in Healthy Volunteers With an EvaluationCompletedNCT01860105Phase 1
- The Antiplatelet and Immune Response TrialCompletedNCT01846559Phase 4
- Comparison of Effect & Safety of Clopidogrel Napadisilate With Clopidogrel Bisulfate in Coronary Artery Disease PatientsCompletedNCT01830491Phase 4
- Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT StudyWithdrawnNCT01826175Phase 4
- Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet TherapyStatus unknownNCT01823185Phase 4
- Efficacy and Safety Study of TicagrelorStatus unknownNCT01812330Phase 3
- Antithrombotic Triple Therapy in HumansCompletedNCT01812200Phase 4
- Uninterrupted Clopidogrel Therapy Before Elective Colonoscopy Will Increase the Risk of Post-polypectomy BleedingCompletedNCT01806090Phase 4
- Effect of Ticagrelor on Endothelial FunctionCompletedNCT01805596Phase 3
- Rapid Activity of Platelet Inhibitor Drugs Study 2CompletedNCT01805570Phase 4
- Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI PatientsCompletedNCT01779401Not applicable
- Standard Clopidogrel Versus Prasugrel Low Dose Therapy in Elderly Patients With Acute Coronary SyndromeStatus unknownNCT01778842Phase 3
- Clinical Trial to Evaluate the Influence of Genotype and DDIs of Aspirin on the PK/PD of Clopidogrel and PK of DigoxinCompletedNCT01775839Phase 4
- A Clinical Study of Safety and P2Y12 Receptor Inhibition Effects of Ticagrelor and Clopidogrel in Vietnamese PatientWithdrawnNCT01757262Phase 3
- Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABGTerminatedNCT01755520Phase 3
- Study to See if Platelet Transfusion Stop or Lessen the Effect of the Drug on PlateletsCompletedNCT01744288Phase 1
- Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic NephropathyStatus unknownNCT01743014Phase 4
- Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary InterventionStatus unknownNCT01738100Phase 2
- Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian PatientsCompletedNCT01706510Phase 4
- Endothelium, Stenting, and Antiplatelet Therapy (EST) - Clopidogrel, Prasugrel, Ticagrelor StudyCompletedNCT01700322Phase 4
- Comparison of Antiplatelet Effect of Ticagrelor vs Tirofiban in Patients With Non-ST Elevation Acute Coronary SyndromeStatus unknownNCT01660373Phase 3
- Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to ClopidogrelStatus unknownNCT01643031Phase 4
- Differential Effect of Ticagrelor Versus Prasugrel on the Adenosine-induced Coronary Vasodilatory Responses in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary InterventionCompletedNCT01642966Phase 4
- Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic StudyCompletedNCT01642940Phase 4
- Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVICompletedNCT01642134Phase 4
- Effect of the Repeated Loading Dose of Clopidogrel and High Dose of Clopidogrel Continuous Therapy on the Platelet Aggregation Inhibition in Patients With Myocardial Infarction Undergoing Interventional Treatment.WithdrawnNCT01636180Phase 4
- Aspirin Versus Clopidogrel Effect on Uterine Blood Flow in Women With Unexplained Recurrent MiscarriagesStatus unknownNCT01635426Phase 2/3
- Residual Platelet Activity In Advanced Peripheral Artery DiseaseStatus unknownNCT01627431Phase 4
- Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fed ConditionsCompletedNCT01621763Phase 1
- Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting ConditionsCompletedNCT01621750Phase 1
- Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?Status unknownNCT01621451Phase 4
- A Pilot Study to Determine the Impact of Clopidogrel (Plavix®) on Bleeding Associated With Punch Biopsies in Healthy VolunteersCompletedNCT01603342Phase 1
- Study to Assess the Pharmacokinetics of AZD6140 After Single Dose in Healthy Japanese Male VolunteersCompletedNCT01588626Phase 1
- Standard (180mg) Versus Double (360mg) Loading Dose of Ticagrelor in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)CompletedNCT01575795Phase 4
- Clopidogrel and Atorvastatin Treatment During Carotid Artery StentingStatus unknownNCT01572623Phase 4
- Clopidogrel Reloading in Patients With NSTEACS Undergoing Percutaneous Coronary Intervention on Chronic Clopidogrel TherapyStatus unknownNCT01572129Phase 4
- Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE TrialCompletedNCT01559298Phase 4
- High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable PatientsCompletedNCT01543932Phase 3
- PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes MellitusCompletedNCT01531114Phase 3
- Bioequivalence Study of Clopidogrel Tablets 75 mg Under Fed ConditionsCompletedNCT01512485Phase 1
- Ticagrelor in Clopidogrel Resistant Patients Undergoing Chronic HemodialysisCompletedNCT01511471Phase 3
- Rapid Activity of Platelet Inhibitor Drugs StudyCompletedNCT01510171Phase 4
- Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27CompletedNCT01509365Phase 4
- Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01506713Phase 1
- Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary InterventionCompletedNCT01505790Phase 3
- Study to Assess Effect of Cyclosporine on the Blood Levels of TicagrelorCompletedNCT01504906Phase 1
- Clinical Trial to Evaluate the Influence of Genotype on the Pharmacokinetics/Pharmacodynamics of ClopidogrelCompletedNCT01503658Phase 4
- The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy VolunteersCompletedNCT01482117Not applicable
- Drug Interaction Study of Clopidogrel and RosuvastatinCompletedNCT01469416Phase 1
- Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE TrialCompletedNCT01465828Phase 3
- Ticagrelor in Comparison to Prasugrel for Early Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI), Undergoing Primary Percutaneous Coronary Intervention (PCI)CompletedNCT01463163Phase 4
- Impact of CYP2C19*17 on the Pharmacokinetics of Proguanil and ClopidogrelCompletedNCT01456546Phase 1
- Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function TestingStatus unknownNCT01456364Phase 4
- Comparative Bioavailability Study of Two Oral Formulations of ClopidogrelTerminatedNCT01447563Phase 1
- Clinical Assessment of Pidogrel® Versus Plavix® (CAPP)CompletedNCT01431495Phase 4
- To Evaluate Whether Acetyl Salicylic Acid (Aspirin), the Combination of Aspirin and Clopidogrel and Darexaban (YM150) Interact in Their EffectsCompletedNCT01409616Phase 1
- Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass SurgeryCompletedNCT01373411Phase 4
- Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary InterventionCompletedNCT01360437Phase 3
- Evaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy VolunteersCompletedNCT01350921Phase 1
- Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary InterventionTerminatedNCT01339026Phase 4
- Atorvastatin and Clopidogrel HIgh DOse in Stable Patients With Residual High Platelet ActivityCompletedNCT01335048Phase 4
- Effect of Platelet Inhibition According to Clopidogrel Dose in Patients With Chronic Kidney DiseaseCompletedNCT01328470Phase 4
- Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese PatientsCompletedNCT01325935Phase 4